15 years of revenue, profit, cash flow and balance-sheet history through FY2025,
from SEC filings — with a computed, factual read of the trend.
Updated Overview →
Growth & profitability
Revenue has grown 6.4% per year over the past 5 years.
Operating margin has contracted, at -869.3% in the latest year.
Financial health
The company is unprofitable and has less than a year of cash runway at its current free-cash-flow burn.
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Return on equity & assets (ROE / ROA)
ROEROA
Free cash flow (CFO − capex)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key annual figures
FY
Revenue
Net income
Gross M
Op M
ROE
ROA
FCF
Total debt
Cash
2025
$2M
-$21M
0.0%
-869.3%
-561.2%
-338.5%
-$22M
—
$3M
2024
$4M
-$25M
0.0%
-635.8%
-495.0%
-306.4%
-$25M
—
$6M
2023
$0
-$26M
—
—
-450.6%
-279.7%
-$25M
—
$6M
2022
$81526
-$14M
0.0%
-17207.5%
-52.7%
-44.7%
-$19M
—
$28M
2021
$385501
-$19M
0.0%
-4862.7%
-425.8%
-157.4%
-$11M
—
$11M
2020
$2M
-$3M
0.0%
-154.5%
-30.9%
-28.5%
-$3M
—
$10M
2019
$1M
-$2M
0.0%
-201.8%
150.6%
-505.6%
-$1M
—
$283341
2018
$963203
-$3M
0.0%
-266.1%
250.4%
-398.7%
—
—
$259701
2017
$1M
-$2M
0.0%
-202.2%
675.9%
-442.7%
-$2M
—
$312727
2016
$828918
-$3M
0.0%
-394.9%
-1361.1%
-536.2%
—
—
$454030
2015
—
-$3M
—
—
-223.3%
-202.0%
-$3M
—
$1M
2014
—
-$3M
—
—
-238.5%
-205.0%
-$2M
—
$1M
2014
—
-$28M
—
—
-1427.9%
-1273.3%
-$20M
—
$2M
2013
—
-$2M
—
—
-90.4%
-80.5%
-$2M
—
$3M
2013
—
-$26M
—
—
-1508.3%
-1334.8%
-$18M
—
$2M
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Return on equity & assets (ROE / ROA)
ROEROA
Free cash flow (CFO − capex, quarterly)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key quarterly figures
Quarter
Revenue
Net income
Gross M
Op M
ROE
ROA
FCF
Total debt
Cash
Jun '26
$0
-$4M
—
—
-251.4%
-95.3%
-$4M
—
$3M
Mar '26
$0
-$5M
—
—
-1065.7%
-176.4%
-$4M
—
$1M
Dec '25
$0
-$4M
—
—
-115.5%
-69.7%
-$5M
—
$3M
Sep '25
$0
-$6M
—
—
-128.8%
-93.9%
-$6M
—
$5M
Jun '25
$852282
-$5M
0.0%
-635.8%
-190.3%
-100.4%
-$4M
—
$3M
Mar '25
$2M
-$5M
0.0%
-330.2%
-67.8%
-49.5%
-$6M
—
$7M
Dec '24
$864415
-$8M
0.0%
-965.3%
-163.7%
-101.3%
-$8M
—
$6M
Sep '24
$3M
-$6M
0.0%
-209.9%
-68.4%
-52.3%
-$9M
—
$9M
Jun '24
$300677
-$5M
0.0%
-1683.6%
219.3%
-123.7%
-$2M
—
$2M
Mar '24
$0
-$6M
—
—
-10778.7%
-174.2%
-$6M
—
$768859
Dec '23
$0
-$8M
—
—
-131.7%
-81.8%
-$10M
—
$6M
Sep '23
$0
-$8M
—
—
-92.2%
-51.9%
-$5M
—
$13M
Jun '23
$0
-$6M
—
—
-34.5%
-27.9%
-$6M
—
$18M
Mar '23
$0
-$4M
—
—
-17.7%
-14.7%
-$4M
—
$24M
Dec '22
$0
-$5M
—
—
-20.2%
-17.2%
-$7M
—
$28M
Sep '22
$0
-$4M
—
—
-12.5%
-10.3%
-$4M
—
$35M
Jun '22
$0
-$2M
—
—
-8.0%
-6.7%
-$4M
—
$31M
Mar '22
$81526
-$2M
0.0%
-2978.2%
-21.4%
-14.4%
-$4M
—
$16M
Dec '21
$164962
-$14M
0.0%
-8331.5%
-315.1%
-116.5%
-$7M
—
$11M
Sep '21
$30414
-$2M
0.0%
-6416.1%
-10.8%
-10.6%
-$2M
—
$18M
Valuation over time
How the market has priced GOVX against its own fundamentals since 2023-03 —
each month-end's share price set against the most recent annual filing, so the multiple moves
as price runs ahead of (or behind) earnings. Split-adjusted.
The price-to-sales ratio has fallen from 60.6× (Mar '23) to 1.5× (Sep '26).
Price / sales (P/S)
P/S
Frequently asked questions
Is GOVX growing its revenue and profit?
Over the past 5 years, GeoVax Labs, Inc.'s revenue has grown 6.4% per year. These are computed facts, not advice.
How much debt does GOVX have?
As of FY2025, GeoVax Labs, Inc. reported — of total debt against $3M of cash.
What is GOVX's profit margin?
In FY2025, gross margin was —, operating margin -869.3%, and net margin -862.3%.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted ·
growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price
against the latest annual filing. Informational only — not investment advice.